Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5‐fluorouracil, oxaliplatin and docetaxel
Explore this paper's citation graph
Summary
Treatment intensification using FLOT was associated with significant pCR rates in patients with oesophagogastric cancer, and the distribution of pCR appeared to be significantly different according to histological type and location of the tumours.
- Type
- article
- Published
- 2012-04-01
- Cited by
- 104
- References
- 39
- OpenAlex
- https://openalex.org/W1988439088
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:5644245
Keywords
Docetaxel, Medicine, Oxaliplatin, Internal medicine, Gastroenterology
References
- Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy
- Prognostic relevance of systematic lymph node dissection in gastric carcinoma
- Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial
- Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.
- High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
- An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer.
- 7-Year Survival Results of Perioperative Chemotherapy with Epidoxorubicin, Etoposide, and Cisplatin (EEP) in Locally Advanced Resectable Gastric Cancer: Up-to-date Analysis of a Phase-II Study
- Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002)
- A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma
- Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy
- Long-Term Follow-Up of a Pilot Phase II Study with Neoadjuvant Epidoxorubicin, Etoposide and Cisplatin in Gastric Cancer
- Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.
- Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma.
- Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
- Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci
- Differential Pathologic Variables and Outcomes across the Spectrum of Adenocarcinoma of the Esophagogastric Junction
- Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial.
- Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
- Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
- Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.
Cited by
- Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma
- Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junction.
- Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge?
- Adenokarzinome des Magens und gastroösophagealen Übergangs
- Diagnostik und Therapie des Magenkarzinoms
- NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma—Very good response predominantly in patients with intestinal type tumors
- Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation
- Erratum to: Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study
- High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal Adenocarcinoma
- SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma.
- Multidisciplinary management of esophageal cancer.
- ASCO-Update 2015 – Neuigkeiten vom 51. Meeting der American Society of Clinical Oncology/ASCO 2015
- Paclitaxel-based regimens as first-line treatment in advanced gastric cancer
- Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer
- Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer
- Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis
- Perioperative Chemotherapy in Gastroesophageal Cancer. A Retrospective Monocenter Evaluation of 42 Cases
- The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+).
- Is Preoperative Chemotherapy Followed by Surgery the Appropriate Treatment for Signet Ring Cell Containing Adenocarcinomas of the Esophagogastric Junction and Stomach?
- Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)dagger.
Related papers
- TS-1 による術後補助療法中に発症しWeekly Docetaxel 療法により著効をみた胃癌腹膜播種の1 例
- The plinabulin/docetaxel combination to mitigate the known safety concerns of docetaxel.
- Docetaxel (Taxotere): preclinical and general clinical information.
- Clinical Observation in the Treatment of Advanced Gastric Cancer with Docetaxel and Oxaliplatin
- Oxaliplatin,fluorouracil,and leucovorin as adjuvant treatment for colon cancer.Andre T,et al.for Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators.N Engl J Med 2004;350:2343-51.PMID:15175436--大腸癌の術後補助化学療法で、初めて多剤併
- Clinical Observation of Oxaliplatin(L-OHP)Combined with Leucovorin and 5-fluorouracil for the Treatment of 37 Patients with Advanced Gastric Carcinoma
- Effect of oxaliplatin combined with 5-fluorouracil on treatment efficacy of radiotherapy in the treatment of elderly patients with rectal cancer
- Clinical Observation of Taxotere in Combination with 5-Fluorouracil,Leucovorin and Oxaliplatin for Hepatic Metastasis of Gastric Cancer
- Oxaliplatin Combined with 5-Fluorouracil for Advanced Gastric Carcinoma:a Report of 42 Cases